OncoSil Medical (ASX:OSL) ROE % Adjusted to Book Value : -67.99% (As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is OncoSil Medical ROE % Adjusted to Book Value?

OncoSil Medical's ROE % for the quarter that ended in Dec. 2024 was -203.98%. OncoSil Medical's PB Ratio for the quarter that ended in Dec. 2024 was 3.00. OncoSil Medical's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -67.99%.

OncoSil Medical ROE % Adjusted to Book Value Historical Data

The historical data trend for OncoSil Medical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoSil Medical ROE % Adjusted to Book Value Chart

OncoSil Medical Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-6.00

-17.02

-27.52

-47.49

-42.76

OncoSil Medical Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-15.48	-64.11	-40.56	-73.29	-67.99

Competitive Comparison of OncoSil Medical's ROE % Adjusted to Book Value

For the Medical Devices subindustry, OncoSil Medical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoSil Medical's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OncoSil Medical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where OncoSil Medical's ROE % Adjusted to Book Value falls into.

OncoSil Medical ROE % Adjusted to Book Value Calculation

OncoSil Medical's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-171.02%	/	4.00
	=	-42.76%

OncoSil Medical's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-203.98%	/	3.00
	=	-67.99%

OncoSil Medical ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of OncoSil Medical's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoSil Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OncoSil Medical Ltd (ASX:OSL) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Eden Park Drive, Level 5, Macquarie Park, Sydney, NSW, AUS, 2113

Website

https://www.oncosil.com

OncoSil Medical Ltd is a medical device company. It is engaged in the development and commercialization of its product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. It operates in one segment. the device development for new medical treatments. Geographically, the company derives its maximum revenue from Europe and the rest from Australia and New Zealand.

OncoSil Medical Headlines

No Headlines